<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <meta name="description" content="InSynBio Smart CAR-T Design Service ‚Äî AI-driven end-to-end engineering for CAR-T, CAR-NK, and CAR-M. From target selection to sequence design and CRO validation.">
  <meta name="keywords" content="CAR-T design, CAR-NK, CAR-M, smart CAR-T, antibody engineering, immunotherapy, InSynBio, AI drug design">
  <meta name="robots" content="index, follow">
  <link rel="canonical" href="https://www.insynbio.com/InSynBio_CART_Design_Page.html">
  <meta property="og:type" content="website">
  <meta property="og:url" content="https://www.insynbio.com/InSynBio_CART_Design_Page.html">
  <meta property="og:title" content="Smart CAR-T Design | InSynBio ‚Äî AI for Life Sciences">
  <meta property="og:description" content="InSynBio Smart CAR-T Design Service ‚Äî AI-driven end-to-end engineering for CAR-T, CAR-NK, and CAR-M. From target selection to sequence design and CRO validation.">
  <meta property="og:image" content="https://www.insynbio.com/images/hero-bg.svg">
  <meta property="twitter:card" content="summary_large_image">
  <meta property="twitter:url" content="https://www.insynbio.com/InSynBio_CART_Design_Page.html">
  <meta property="twitter:title" content="Smart CAR-T Design | InSynBio ‚Äî AI for Life Sciences">
  <meta property="twitter:description" content="InSynBio Smart CAR-T Design Service ‚Äî AI-driven end-to-end engineering for CAR-T, CAR-NK, and CAR-M. From target selection to sequence design and CRO validation.">
  <meta property="twitter:image" content="https://www.insynbio.com/images/hero-bg.svg">
  <title>Smart CAR-T Design | InSynBio ‚Äî AI for Life Sciences</title>
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Cormorant+Garamond:ital,wght@0,500;0,600;0,700;1,500&family=Noto+Sans+SC:wght@400;500&display=swap" rel="stylesheet">
  <style>
    :root { --primary: #0d9488; --primary-dark: #0f766e; --text: #1f2937; --text-muted: #6b7280; --border: #e5e7eb; --bg: #ffffff; --bg-alt: #f9fafb; }
    * { box-sizing: border-box; }
    body { margin: 0; font-family: 'Inter', -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif; font-size: 16px; line-height: 1.6; color: var(--text); background: var(--bg-alt); }
    /* T-shaped: top header + sidebar + main */
    .top-header { display: flex; align-items: center; justify-content: space-between; padding: 10px 24px; background: var(--bg); border-bottom: 1px solid var(--border); flex-shrink: 0; gap: 16px; flex-wrap: wrap; }
    .top-header .brand { font-family: 'Cormorant Garamond', Georgia, serif; font-weight: 600; font-size: 24px; letter-spacing: -0.02em; display: flex; align-items: center; }
    .top-header .brand a { text-decoration: none; color: inherit; display: flex; align-items: center; gap: 9px; }
    .top-header .brand .syn { color: var(--primary); font-style: italic; font-weight: 700; }
    .top-header .slogan { font-size: 13px; color: var(--text-muted); margin-left: 0; padding-left: 14px; border-left: 1px solid var(--border); font-family: 'Inter', sans-serif; white-space: nowrap; }
    .top-header-nav { display: flex; align-items: center; gap: 8px; flex: 1; justify-content: center; }
    .top-header-nav a { padding: 8px 14px; font-size: 14px; color: var(--text-muted); text-decoration: none; border-radius: 6px; transition: all 0.2s; }
    .top-header-nav a:hover { color: var(--primary); background: var(--bg-alt); }
    .nav-dropdown { position: relative; }
    .nav-dropdown > a::after { content: ' ‚ñæ'; font-size: 10px; opacity: 0.7; }
    .nav-dropdown .dropdown-menu { position: absolute; top: 100%; left: 0; min-width: 160px; padding: 6px 0; background: var(--bg); border: 1px solid var(--border); border-radius: 8px; box-shadow: 0 4px 12px rgba(0,0,0,0.08); opacity: 0; visibility: hidden; transform: translateY(-4px); transition: all 0.2s; z-index: 100; }
    .nav-dropdown:hover .dropdown-menu,
    .nav-dropdown:focus-within .dropdown-menu { opacity: 1; visibility: visible; transform: translateY(0); }
    .nav-dropdown .dropdown-menu a { display: block; padding: 10px 16px; color: var(--text); text-decoration: none; line-height: 1.4; border-radius: 0; white-space: normal; }
    .nav-dropdown .dropdown-menu a:hover { background: var(--bg-alt); }
    .nav-dropdown .dropdown-menu a .menu-title { display: block; font-weight: 600; font-size: 14px; color: var(--text); }
    .nav-dropdown .dropdown-menu a:hover .menu-title { color: var(--primary); }
    .nav-dropdown .dropdown-menu a .menu-desc { display: block; font-size: 12px; color: var(--text-muted); font-weight: 400; margin-top: 2px; }
    .top-header-nav a.active { background: var(--primary); color: #fff; font-weight: 500; }
    .top-header-nav a.active:hover,
    .top-header-nav a.active:focus { background: var(--primary-dark); color: #fff; }
    .top-header-nav a[href="index.html"] { background: transparent; color: var(--text-muted); }
    .top-header-nav a[href="index.html"].active { background: var(--primary); color: #fff; font-weight: 500; }
    .top-header-nav a[href="index.html"].active:hover,
    .top-header-nav a[href="index.html"].active:focus { background: var(--primary-dark); color: #fff; }
    .top-header-nav a[href="index.html"]:hover { color: var(--primary); background: var(--bg-alt); }
    .top-header .header-right { display: flex; align-items: center; gap: 16px; }
    .top-header 
    .page-wrap { display: flex; min-height: calc(100vh - 57px); }
    .sidebar { width: 260px; flex-shrink: 0; background: var(--bg); border-right: 1px solid var(--border); padding: 28px 0; position: sticky; top: 0; height: 100vh; overflow-y: auto; }
    .sidebar h3 { font-size: 12px; font-weight: 600; color: var(--text-muted); margin: 0 24px 12px; padding-top: 4px; text-transform: uppercase; letter-spacing: 1px; }
    .sidebar nav a { display: flex; align-items: center; padding: 12px 24px; color: var(--text); text-decoration: none; font-size: 15px; transition: all 0.2s; border-left: 3px solid transparent; }
    .sidebar nav a:hover { background: var(--bg-alt); color: var(--primary); }
    .sidebar nav a.active { background: #f0fdfa; color: var(--primary-dark); border-left-color: var(--primary); font-weight: 500; }
    .nav-icon { width: 18px; height: 18px; margin-right: 10px; opacity: 0.7; flex-shrink: 0; }
    .main { flex: 1; padding: 36px 48px 64px; max-width: 920px; }
    .main h1 { font-size: 32px; font-weight: 700; color: var(--text); margin: 0 0 12px; letter-spacing: -0.02em; }
    .main .subtitle { font-size: 17px; color: var(--text-muted); margin-bottom: 4px; }
    .main h2 { font-size: 21px; font-weight: 600; color: var(--text); margin: 36px 0 16px; padding-top: 28px; border-top: 1px solid var(--border); }
    .main h2:first-of-type { margin-top: 0; padding-top: 0; border-top: none; }
    .main h2#library { font-size: 26px; font-weight: 700; }
    .h2-icon { display: inline-flex; align-items: center; justify-content: center; width: 32px; height: 32px; margin-right: 10px; border-radius: 8px; background: rgba(13,148,136,0.12); color: var(--primary); vertical-align: middle; }
    .main p, .main ul, .main li { margin: 0 0 16px; color: var(--text); font-size: 16px; }
    .main ul { padding-left: 24px; }
    .main li { margin-bottom: 10px; }
    .main .input-note { font-size: 14px; color: var(--text-muted); margin-top: 8px; }
    .form-section { background: var(--bg); border-radius: 12px; padding: 32px; margin-top: 32px; box-shadow: 0 1px 3px rgba(0,0,0,0.06); border: 1px solid var(--border); }
    .form-row { display: flex; gap: 24px; margin-bottom: 24px; flex-wrap: wrap; }
    .form-group { flex: 1; min-width: 180px; }
    .form-group.full { flex: 1 1 100%; }
    .form-group label { display: block; font-weight: 500; margin-bottom: 8px; color: var(--text); font-size: 14px; }
    .form-group input, .form-group select, .form-group textarea { width: 100%; padding: 12px 14px; border: 1px solid var(--border); border-radius: 8px; font-size: 14px; font-family: inherit; }
    .form-group textarea { min-height: 100px; resize: vertical; }
    .form-group textarea.seq { font-family: 'Consolas', 'Monaco', monospace; font-size: 13px; min-height: 80px; }
    .form-group input:focus, .form-group select:focus, .form-group textarea:focus { outline: none; border-color: var(--primary); box-shadow: 0 0 0 2px rgba(13,148,136,0.15); }
    .form-group .hint { font-size: 13px; color: var(--text-muted); margin-top: 6px; }
    .form-group .hint a { color: var(--primary); }
    .btn { padding: 14px 28px; background: var(--primary); color: #fff; border: none; border-radius: 8px; font-size: 15px; font-weight: 500; cursor: pointer; }
    .btn:hover { background: var(--primary-dark); }
    .check-group { display: flex; flex-wrap: wrap; gap: 16px; margin: 16px 0; }
    .check-item { display: flex; align-items: center; gap: 10px; }
    .check-item input { width: 18px; height: 18px; }
    .check-item label { margin: 0; font-weight: 400; cursor: pointer; }
    .breadcrumb { font-size: 14px; color: var(--text-muted); margin-bottom: 28px; }
    .breadcrumb a { color: var(--primary); text-decoration: none; }
    .breadcrumb a:hover { text-decoration: underline; }
    .breadcrumb span { color: #d1d5db; margin: 0 8px; }
    .table-wrap { overflow-x: auto; margin: 24px 0; border-radius: 6px; border: 1px solid var(--border); }
    .main table { min-width: 100%; background: var(--bg); border-collapse: separate; border-spacing: 0; border-radius: 8px; overflow: hidden; border: 1px solid var(--border); }
    .main table th, .main table td { padding: 16px 20px; border: none; border-bottom: 1px solid var(--border); font-size: 15px; color: var(--text); text-align: left; }
    .main table th { background: #f8fafc; font-weight: 700; color: #0f172a; text-transform: uppercase; font-size: 14px; letter-spacing: 0.05em; }
    .main table tr:last-child td { border-bottom: none; }
    .main table tr:hover td { background-color: #f9fafb; }
    .main table th:nth-child(4), .main table td:nth-child(4) { word-break: break-word; white-space: normal; min-width: 180px; }
    .main table .status-link { display: inline-block; font-size: 12px; font-weight: 600; color: var(--primary); background: rgba(13,148,136,0.08); padding: 2px 9px; border-radius: 20px; text-decoration: none; }
    .main table .status-link:hover { background: rgba(13,148,136,0.15); color: var(--primary-dark); }
    .disclaimer { font-size: 14px; color: var(--text-muted); font-style: italic; margin-top: 12px; padding: 12px 16px; background: #fffbeb; border-left: 4px solid #f59e0b; border-radius: 0 6px 6px 0; }
    .file-upload-wrap { display: flex; align-items: center; gap: 12px; flex-wrap: wrap; }
    .file-input-hidden { position: absolute; width: 0.1px; height: 0.1px; opacity: 0; overflow: hidden; z-index: -1; }
    .file-upload-btn { padding: 10px 18px; background: var(--bg-alt); border: 1px solid var(--border); border-radius: 6px; font-size: 14px; cursor: pointer; color: var(--text); }
    .file-upload-btn:hover { border-color: var(--primary); color: var(--primary); }
    .file-upload-name { font-size: 14px; color: var(--text-muted); }
    .brand-logo { font-family: 'Cormorant Garamond', Georgia, serif; font-weight: 600; font-size: 28px; letter-spacing: -0.02em; line-height: 1.2; margin-bottom: 24px; padding: 0 24px; }
    .brand-logo a { text-decoration: none; color: inherit; display: inline-block; transition: opacity 0.2s; }
    .brand-logo a:hover { opacity: 0.85; }
    .brand-logo .in { color: var(--text); }
    .brand-logo .syn { color: var(--primary); font-style: italic; font-weight: 700; }
    .brand-logo .bio { color: var(--text); }
    .brand-logo .tagline { font-family: 'Inter', sans-serif; font-size: 10px; font-weight: 500; color: var(--text-muted); text-transform: uppercase; letter-spacing: 1.5px; margin-top: 4px; font-style: normal; }

    .site-footer { margin-top: 48px; padding-top: 24px; border-top: 1px solid var(--border); font-size: 13px; color: var(--text-muted); text-align: center; }
    .site-footer a { color: var(--primary); text-decoration: none; }
    .site-footer a:hover { text-decoration: underline; }
    .mission-block { background-color: #ffffff; background-image: linear-gradient(to bottom, rgba(255,255,255,0.9) 0%, rgba(255,255,255,0.95) 100%), url('images/hero-bg.svg'); background-size: cover; background-position: center; border-radius: 12px; padding: 32px; margin-bottom: 32px; border: 1px solid rgba(13,148,136,0.1); border-left: 4px solid var(--primary); box-shadow: 0 4px 12px rgba(13,148,136,0.05); }
    .mission-block p { margin: 0; font-size: 16px; line-height: 1.7; color: var(--text); }
    .mission-block p + p { margin-top: 14px; }
    
    /* Responsive styles */
    @media (max-width: 900px) {
      .top-header { flex-wrap: wrap; padding: 12px 16px; gap: 10px; }
      .top-header .brand { flex: 1 1 auto; min-width: 0; display: flex; align-items: center; flex-wrap: wrap; gap: 8px; }
      .top-header .slogan { display: inline-block !important; font-size: 12px; padding-left: 10px; border-left: 1px solid var(--border); white-space: nowrap; }
      .top-header .header-right { order: 2; margin-left: auto; }
      .top-header-nav { order: 3; width: 100%; flex: 1 1 100%; justify-content: flex-start; flex-wrap: wrap; gap: 6px; overflow-x: auto; padding-bottom: 4px; -webkit-overflow-scrolling: touch; border-top: 1px solid var(--border); padding-top: 10px; margin-top: 2px; }
      .top-header-nav a { flex-shrink: 0; font-size: 13px; padding: 6px 10px; }
      .page-wrap { flex-direction: column; min-height: auto; }
      .sidebar { width: 100%; height: auto; position: relative; border-right: none; border-bottom: 1px solid #e0e0e0; padding: 16px; }
      .sidebar nav { display: flex; flex-wrap: wrap; gap: 8px; }
      .sidebar nav a { display: inline-flex; padding: 8px 12px; border-radius: 6px; border-left: none; }
      .main { padding: 24px 24px 48px; }
      .mission-block { padding: 20px; margin-bottom: 24px; }
    }
  </style>
</head>
<body data-lang="en" id="insynbio-body">
  <header class="top-header">
    <div class="brand">
      <a href="index.html" style="display: flex; align-items: center; gap: 10px; text-decoration: none;">
        <svg width="32" height="32" viewBox="0 0 32 32" fill="none" xmlns="http://www.w3.org/2000/svg">
          <defs>
            <linearGradient id="logo_grad_2" x1="0" y1="0" x2="32" y2="32" gradientUnits="userSpaceOnUse">
              <stop stop-color="#0d9488" />
              <stop offset="1" stop-color="#2dd4bf" />
            </linearGradient>
          </defs>
          <path d="M7 6L16 18V28" stroke="url(#logo_grad_2)" stroke-width="3" stroke-linecap="round" stroke-linejoin="round"/>
          <path d="M25 6L16 18" stroke="url(#logo_grad_2)" stroke-width="3" stroke-linecap="round" stroke-linejoin="round"/>
          <circle cx="7" cy="6" r="2" fill="#0f766e" />
          <circle cx="25" cy="6" r="2" fill="#0f766e" />
          <circle cx="16" cy="18" r="2" fill="white" stroke="#0d9488" stroke-width="1.5"/>
        </svg>
        <span style="font-family: 'Cormorant Garamond', serif; font-weight: 700; font-size: 26px; color: #1f2937; letter-spacing: -0.02em;">
          In<span style="color: #0d9488;">Syn</span>Bio
        </span>
      </a>
      <span class="slogan">AI for Life Sciences</span>
      
    </div>
    <nav class="top-header-nav">
      <a href="index.html">Home</a>
      <a href="index.html#about">About Us</a>
      <div class="nav-dropdown" tabindex="0">
        <a href="index.html#services">Services</a>
        <div class="dropdown-menu">
          <a href="InSynBio_Antibody_Developability_Assessment_Page.html">
            <span class="menu-title">Antibody</span>
            <span class="menu-desc">Structure-based Development</span>
          </a>
          <a href="#platform">
            <span class="menu-title">CAR-T</span>
            <span class="menu-desc">Smart CAR-T Design</span>
          </a>
          <a href="InSynBio_Bispecific_Antibody_Design_Page.html">
            <span class="menu-title">Bispecific</span>
            <span class="menu-desc">Multispecific Engineering</span>
          </a>
        </div>
      </div>
      <a href="#submit">Submit Inquiry</a>
      <a href="#contact">Contact</a>
    </nav>
    
  </header>
  <div class="page-wrap">
    <aside class="sidebar">
      <h3>Smart CAR-T</h3>
      
      <nav>
        <a href="#platform" class="nav-link active">
          <svg class="nav-icon" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><rect x="3" y="3" width="7" height="7"/><rect x="14" y="3" width="7" height="7"/><rect x="3" y="14" width="7" height="7"/><rect x="14" y="14" width="7" height="7"/></svg>
          Platform
        </a>
        <a href="#library" class="nav-link"><svg class="nav-icon" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M4 19.5A2.5 2.5 0 0 1 6.5 17H20"/><path d="M6.5 2H20v20H6.5A2.5 2.5 0 0 1 4 19.5v-15A2.5 2.5 0 0 1 6.5 2z"/></svg>Component Library</a>
        <a href="#strategy" class="nav-link"><svg class="nav-icon" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M22 12h-4l-3 9L9 3l-3 9H2"/></svg>Disease Strategy</a>
        <a href="#engineering" class="nav-link"><svg class="nav-icon" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M14.7 6.3a1 1 0 0 0 0 1.4l1.6 1.6a1 1 0 0 0 1.4 0l3.77-3.77a6 6 0 0 1-7.94 7.94l-6.91 6.91a2.12 2.12 0 0 1-3-3l6.91-6.91a6 6 0 0 1 7.94-7.94l-3.76 3.76z"/></svg>Engineering</a>
        <a href="#example" class="nav-link"><svg class="nav-icon" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><polyline points="4 17 10 11 4 5"/><line x1="12" y1="19" x2="20" y2="19"/></svg>Case Study</a>
        <a href="#safety" class="nav-link"><svg class="nav-icon" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M12 22s8-4 8-10V5l-8-3-8 3v7c0 6 8 10 8 10z"/></svg>Safety & Efficacy</a>
        <a href="#full-report" class="nav-link"><svg class="nav-icon" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M14 2H6a2 2 0 0 0-2 2v16a2 2 0 0 0 2 2h12a2 2 0 0 0 2-2V8z"/><polyline points="14 2 14 8 20 8"/><line x1="16" y1="13" x2="8" y2="13"/><line x1="16" y1="17" x2="8" y2="17"/><polyline points="10 9 9 9 8 9"/></svg>Full Report</a>
        <a href="#submit" class="nav-link"><svg class="nav-icon" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><line x1="22" y1="2" x2="11" y2="13"/><polygon points="22 2 15 22 11 13 2 9 22 2"/></svg>Submit Inquiry</a>
        <a href="#contact" class="nav-link"><svg class="nav-icon" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M4 4h16c1.1 0 2 .9 2 2v12c0 1.1-.9 2-2 2H4c-1.1 0-2-.9-2-2V6c0-1.1.9-2 2-2z"/><polyline points="22,6 12,13 2,6"/></svg>Contact</a>
      </nav>
    </aside>
    <main class="main">
      <div class="breadcrumb">
        <a href="index.html">Home</a><span>/</span><a href="index.html#services">Services</a><span>/</span><span>Smart CAR-T</span>
      </div>

      <!-- Hero / Mission (same structure as Antibody page) -->
      <div class="mission-block">
        <p><strong>Smart CAR-T Design:</strong> AI-driven end-to-end engineering service. From target selection to sequence design and CRO validation. We provide rational design frameworks for Solid Tumors, Hematologic Malignancies, and Autoimmune Diseases.</p>
        
        <p>Our ACTES platform combines a proprietary library of nearly 200 curated components with antigen knowledge base, smart vector logic, epitope‚Äìhinge matching, and affinity tuning. We support lentiviral, non-viral, and in vivo delivery strategies and offer CRO-ready validation support. <a href="index.html#about">Learn more ‚Üí</a></p>
        
      </div>

      <h1>Smart CAR-T Design</h1>
      <p class="subtitle">AI-Driven End-to-End Engineering: From Target to Sequence, From Sequence to System.</p>
      
      <p class="disclaimer">Disclaimer: InSynBio in silico analyses are for reference only and do not replace final wet-lab validation. Experimental confirmation is required.</p>

      <h2 id="platform"><span class="h2-icon"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><rect x="3" y="3" width="7" height="7"/><rect x="14" y="3" width="7" height="7"/><rect x="3" y="14" width="7" height="7"/><rect x="14" y="14" width="7" height="7"/></svg></span>AI-Native Design Platform</h2>
      <p>Our ACTES platform leverages a proprietary library of <strong>nearly 200 curated components</strong> across 10 categories. We don't just assemble; we match.</p>
      
      <ul>
        <li><strong>Antigen Knowledge Base</strong> ‚Äî A continuously updated database of <strong>common epitopes</strong>, <strong>antigen density</strong> thresholds, <strong>heterogeneity</strong> profiles, <strong>disease context</strong> (solid vs. hematologic vs. autoimmune), and <strong>specificity</strong> considerations (e.g. on-target off-tumor risk) to guide precise design.</li>
        <li><strong>Smart Vector Logic</strong> ‚Äî Algorithmic selection between <strong>Lentiviral</strong> (Standard), <strong>Non-Viral/Transposon</strong> (Large Payload), and <strong>In Vivo LNP</strong> (Accessibility) based on clinical needs.</li>
        <li><strong>Epitope-Hinge Matching</strong> ‚Äî We measure epitope-to-membrane distance using <strong>AlphaFold2</strong> to select the precise Hinge length (Short/Medium/Long).</li>
        <li><strong>Kinetic Engineering</strong> ‚Äî We tune Binder affinity (Kd) and off-rates (koff) via computational mutagenesis. We increase affinity for low-density targets, but tune it down for targets like HER2 to spare normal tissues, while ensuring fast dissociation to prevent exhaustion.</li>
        <li><strong>Density-Signaling Logic</strong> ‚Äî We analyze antigen density to select the optimal Transmembrane (CD8Œ± vs CD28) and Signaling domains (4-1BB vs CD28).</li>
      </ul>

      <h2 id="library"><span class="h2-icon"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M4 19.5A2.5 2.5 0 0 1 6.5 17H20"/><path d="M6.5 2H20v20H6.5A2.5 2.5 0 0 1 4 19.5v-15A2.5 2.5 0 0 1 6.5 2z"/></svg></span>Proprietary Component Library</h2>
      <p>Our ACTES platform houses a continuously updated library of <strong>nearly 200 curated components</strong> across 10 major categories, spanning clinical standards to frontier modalities.</p>

      <div class="table-wrap">
      <table style="width:100%; border-collapse: collapse; font-size: 13px;">
        <thead>
          <tr>
            <th style="width: 11%;">Category</th>
            <th style="width: 16%;">Function</th>
            <th style="width: 32%;">Clinical Standards (Validated)</th>
            <th style="width: 41%; min-width: 200px;">Frontier Modalities (Emerging)</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td><strong>Binders</strong></td>
            <td>Target recognition</td>
            <td>scFv (FMC63, Trastuzumab, 14G2a, SS1, m971, 4D5, 225), Humanized scFv, Fab Fragments</td>
            <td>VHH/Nanobody (Solid Tumor), TCR-mimic (WT1, KRAS, NY-ESO-1, MAGE-A4), Centyrins, DARPins, Ligand-based (IL-13, APRIL), Computational Mask Design (FTO-Focused), Peptide Binders</td>
          </tr>
          <tr>
            <td><strong>Hinge</strong></td>
            <td>Epitope distance matching</td>
            <td>CD8Œ± Short (45aa), IgG4 Long (228aa), CD28 Medium, IgG1 Hinge</td>
            <td>IgG4-SPLE (Fc-Null/S228P), Auto-Hinge (AI-Matched), IgD Hinge (Protease Resistant), CD8Œ±-Long (119aa), Synthetic Flexible Linkers, Rigid EAAAK Linkers</td>
          </tr>
          <tr>
            <td><strong>Transmembrane</strong></td>
            <td>Anchoring & signaling threshold</td>
            <td>CD8Œ± TM (Low tonic), CD28 TM (Lipid raft), CD4 TM</td>
            <td>NKG2D TM (NK Optimization), DAP10 TM, DAP12 TM, ICOS TM, OX40 TM, In Vivo Optimized TM (LNP-compatible)</td>
          </tr>
          <tr>
            <td><strong>Co-stimulatory</strong></td>
            <td>Metabolism & Persistence</td>
            <td>4-1BB (Mitochondrial), CD28 (Glycolytic)</td>
            <td>OX40 (CD134), ICOS (Th17/Th1), 2B4 (CD244), DAP10, CD27, GITR, HVEM, CD40, MyD88, TLR2, 4-1BBL (Self-Driving)</td>
          </tr>
          <tr>
            <td><strong>Activation</strong></td>
            <td>Killing signal</td>
            <td>CD3Œ∂ (3x ITAM)</td>
            <td>DAP12 (CAR-NK/Macrophage), FcR-Œ≥ (Phagocytosis), CD3Œµ (Recruitment), ZAP70 recruitment motifs, 1XX (Calibrated ITAMs)</td>
          </tr>
          <tr>
            <td><strong>Armored Payloads</strong></td>
            <td>TME remodeling & Resistance</td>
            <td>Secreted IL-12 (TRUCK), Constitutive IL-15</td>
            <td>TGFB_DNR (Anti-Suppression), Membrane_IL15/IL-21, GPX4_Enhanced (Anti-Ferroptosis), IL-7/CCL19 (7x19), c-JUN, HPSE (Heparanase), scFv-PD1 blocker, BiTE secretion</td>
          </tr>
          <tr>
            <td><strong>Safety Switches</strong></td>
            <td>Controllable elimination</td>
            <td>tEGFR (Cetuximab), CD20 Mimotope (Rituximab)</td>
            <td>iCasp9 (Small Molecule, >95%), RQR8 (Dual Tag), Rapamycin-ON, Lenalidomide-ON, HSV-TK, TMPD-inducible</td>
          </tr>
          <tr>
            <td><strong>Logic Gates</strong></td>
            <td>Specificity control (AND/NOT)</td>
            <td>Tandem CAR (OR Gate)</td>
            <td>SynNotch (AND Gate), iCAR (NOT Gate/PD-1/CTLA-4), Split CAR (Dimerization), LOCKR (Protein Switch), CLIP-CAR, Universal CAR (BBIR)</td>
          </tr>
          <tr>
            <td><strong>Regulatory</strong></td>
            <td>Expression control</td>
            <td>EF1Œ± Promoter, PGK Promoter, WPRE</td>
            <td>NFAT_Response (Inducible), UCOE (Anti-Silencing), Tet-On/Tet-Off, SFFV, CMV, SV40, EFS (Compact), JeT promoter</td>
          </tr>
          <tr>
            <td><strong>Leaders & Linkers</strong></td>
            <td>Secretion & Flexibility</td>
            <td>CD8Œ± SP, GM-CSF SP, G4S (Flexible)</td>
            <td>IL-2 SP (Secretion), Gaussia SP, EAAAK3 (Rigid), Whitlow Linker, 218 Linker, XTEN, Furin-P2A/T2A/E2A/F2A</td>
          </tr>
        </tbody>
      </table>
      </div>

      <h2 id="strategy"><span class="h2-icon"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M22 12h-4l-3 9L9 3l-3 9H2"/></svg></span>Therapeutic Architecture Matrix</h2>
      <p>Our AI engine applies deep biological logic to select the optimal architecture. We don't just assemble parts; we design <strong>systems</strong> to overcome specific disease barriers.</p>
      
      <div class="table-wrap">
      <table style="width:100%; border-collapse: collapse;">
        <thead>
          <tr>
            <th>Disease Context</th>
            <th>Critical Barriers</th>
            <th>Advanced Architectural Solution</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td><strong>Solid Tumors (e.g., HCC, Gastric)</strong></td>
            <td><strong>Physical Exclusion</strong> (ECM), <strong>Immunosuppression</strong> (TGF-Œ≤) & <strong>On-Target Off-Tumor</strong></td>
            <td><strong>Matrix-Degrading Synergy:</strong> CAR-M to degrade ECM + CAR-T armored with <strong>TGFB_DNR</strong>. <strong>Affinity Tuning</strong> (lower Kd on normal-tissue antigens) and <strong>Logic-Gated</strong> recognition to spare healthy tissue.</td>
          </tr>
          <tr>
            <td><strong>Hematologic / Liquid Tumors (e.g., B-ALL, LBCL)</strong></td>
            <td><strong>Cytokine Storm (CRS)</strong> & <strong>B-cell Aplasia</strong></td>
            <td><strong>4-1BB-Dominant</strong> (reduced CRS vs CD28), <strong>Safety Switches</strong> (tEGFR, iCasp9) for controllable elimination, <strong>Tuned Affinity</strong> and dose to balance efficacy and toxicity.</td>
          </tr>
          <tr>
            <td><strong>AML / Myeloid Malignancies</strong></td>
            <td><strong>Shared Toxicity</strong> (Healthy marrow depletion) & <strong>Relapse</strong></td>
            <td><strong>Transient "Hit-and-Run":</strong> <strong>mRNA-LNP In Vivo CAR</strong> for temporary clearance without permanent aplasia, or <strong>Logic-Gated (NOT)</strong> circuits.</td>
          </tr>
          <tr>
            <td><strong>Autoimmune (SLE, Lupus)</strong></td>
            <td><strong>Systemic Safety</strong> & <strong>B-cell Aplasia</strong> risks</td>
            <td><strong>Immune Reset:</strong> <strong>CD8-Sparing CAR-Treg</strong> to induce tolerance, or <strong>Short-Lived mRNA CAR</strong> to deplete B-cells once, allowing immune reboot.</td>
          </tr>
          <tr>
            <td><strong>CNS / Glioblastoma</strong></td>
            <td><strong>Blood-Brain Barrier</strong> & <strong>Neurotoxicity (ICANS)</strong></td>
            <td><strong>Regional Precision:</strong> <strong>Intracavitary Delivery</strong> (ICV) bypasses BBB. <strong>Hinge/TM Optimization</strong> minimizes tonic signaling to reduce ICANS risk.</td>
          </tr>
        </tbody>
      </table>
      </div>

      <h2 id="engineering"><span class="h2-icon"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M14.7 6.3a1 1 0 0 0 0 1.4l1.6 1.6a1 1 0 0 0 1.4 0l3.77-3.77a6 6 0 0 1-7.94 7.94l-6.91 6.91a2.12 2.12 0 0 1-3-3l6.91-6.91a6 6 0 0 1 7.94-7.94l-3.76 3.76z"/></svg></span>Engineering Modules</h2>
      <p>We assemble the optimal CAR construct using a validated library of functional domains.</p>
      
      <ul>
        <li><strong>Advanced Binders</strong> ‚Äî <strong>De Novo Mask Design</strong> (Computational FTO), <strong>Logic-Gated</strong> recognition, and <strong>Multi-specifics</strong> (BiTE/TriTE secretion).</li>
        <li><strong>Next-Gen Signaling</strong> ‚Äî <strong>JAK-STAT</strong> (IL-2RŒ≤) integration (5th Gen), <strong>BATF3-programming</strong> for stemness, and <strong>Synthetic Costimulation</strong> (e.g., 4-1BBL/CD40L).</li>
        <li><strong>In Vivo Delivery</strong> ‚Äî <strong>LNP-optimized mRNA</strong> (Transient/Safe), <strong>Viral-Like Particles (VLP)</strong> (Targeted), and <strong>AAV</strong> (Donor Template) vectors.</li>
        <li><strong>Allogeneic Engineering</strong> ‚Äî <strong>CRISPR/Cas9</strong> gene editing (TRAC/B2M KO) for off-the-shelf universal CAR-T, mitigating GvHD and rejection.</li>
        <li><strong>Armoring (Payloads)</strong> ‚Äî <strong>TGFB_DNR</strong> (Anti-suppression), <strong>Membrane_IL15</strong> (Persistence), <strong>GPX4</strong> (Anti-ferroptosis), <strong>Secreted IL-12</strong> (TRUCK).</li>
        <li><strong>Affinity Tuning</strong> ‚Äî Computational mutagenesis to tune Kd (e.g., lowering affinity for HER2 to spare normal tissue) and k_off (preventing exhaustion).</li>
        <li><strong>Vector & Capacity</strong> ‚Äî <strong>Compact VHH</strong> designs to save payload space; <strong>PiggyBac / Sleeping Beauty Transposon</strong> support for ultra-large constructs (>10kb) surpassing lentiviral limits.</li>
      </ul>

      <h2 id="example"><span class="h2-icon"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><polyline points="4 17 10 11 4 5"/><line x1="12" y1="19" x2="20" y2="19"/></svg></span>Design Example: GPC3 CAR-T Logic Trace</h2>
      <p>The ACTES engine doesn't just pick parts; it reasons through the biology. Here is the deduction process for a Hepatocellular Carcinoma (HCC) project.</p>

      <div class="logic-box" style="background: #f8fafc; border: 1px solid #e2e8f0; border-radius: 8px; padding: 24px; font-family: 'Inter', sans-serif;">
        <div style="border-bottom: 1px solid #e2e8f0; padding-bottom: 12px; margin-bottom: 16px;">
            <strong style="color: var(--primary); font-size: 14px; text-transform: uppercase;">Input Parameters</strong><br>
            <span style="font-family: monospace; color: var(--text-muted);">Target: GPC3 | Indication: Solid Tumor (HCC) | Delivery: Lentiviral</span>
        </div>

        <div class="step" style="margin-bottom: 16px;">
            <strong style="color: #0f172a;">Step 1: Structural Topology Analysis</strong><br>
            <span style="color: var(--text-muted); font-size: 14px;">‚Ä¢ Query: Where is the epitope located on GPC3?</span><br>
            <span style="color: var(--primary); font-weight: 500; font-size: 14px;">‚Üí Result: Membrane Proximal (&lt; 5nm distance).</span><br>
            <div style="background: rgba(13,148,136,0.1); padding: 8px 12px; border-radius: 6px; margin-top: 6px; font-size: 13px; color: var(--primary-dark);">
                <strong>üí° AI Decision:</strong> Enforce <strong>CD8Œ± Short Hinge</strong>. <br>
                <em>Reasoning: A Long Hinge (e.g., IgG4) would push the CAR too far from the target, preventing effective immunological synapse formation.</em>
            </div>
        </div>

        <div class="step" style="margin-bottom: 16px;">
            <strong style="color: #0f172a;">Step 2: TME Counter-Strategy</strong><br>
            <span style="color: var(--text-muted); font-size: 14px;">‚Ä¢ Query: What are the suppression factors in HCC?</span><br>
            <span style="color: var(--primary); font-weight: 500; font-size: 14px;">‚Üí Result: High TGF-Œ≤ + Hypoxia.</span><br>
            <div style="background: rgba(13,148,136,0.1); padding: 8px 12px; border-radius: 6px; margin-top: 6px; font-size: 13px; color: var(--primary-dark);">
                <strong>üí° AI Decision:</strong> Add <strong>TGFB_DNR</strong> (Dominant Negative Receptor). <br>
                <em>Reasoning: Shields CAR-T from TGF-Œ≤ inhibition, converting the "stop" signal into a survival advantage.</em>
            </div>
        </div>

        <div class="step" style="margin-bottom: 16px;">
            <strong style="color: #0f172a;">Step 3: Safety & Toxicity</strong><br>
            <span style="color: var(--text-muted); font-size: 14px;">‚Ä¢ Query: Is GPC3 expressed on normal tissues?</span><br>
            <span style="color: var(--primary); font-weight: 500; font-size: 14px;">‚Üí Result: Low expression on normal liver/lung.</span><br>
            <div style="background: rgba(13,148,136,0.1); padding: 8px 12px; border-radius: 6px; margin-top: 6px; font-size: 13px; color: var(--primary-dark);">
                <strong>üí° AI Decision:</strong> Equip <strong>iCasp9 Safety Switch</strong>. <br>
                <em>Reasoning: Mandatory fail-safe to terminate therapy in case of severe on-target/off-tumor toxicity.</em>
            </div>
        </div>

        <div class="step">
            <strong style="color: #0f172a;">Step 4: Kinetics Tuning</strong><br>
            <span style="color: var(--text-muted); font-size: 14px;">‚Ä¢ Query: Risk of exhaustion in solid tumor?</span><br>
            <span style="color: var(--primary); font-weight: 500; font-size: 14px;">‚Üí Result: High. Requires serial killing persistence.</span><br>
            <div style="background: rgba(13,148,136,0.1); padding: 8px 12px; border-radius: 6px; margin-top: 6px; font-size: 13px; color: var(--primary-dark);">
                <strong>üí° AI Decision:</strong> Optimize for <strong>Fast Off-Rate (koff)</strong>. <br>
                <em>Reasoning: Prevents chronic signaling and exhaustion, allowing CAR-T cells to detach and engage multiple tumor targets sequentially.</em>
            </div>
        </div>
      </div>

      <h2 id="safety"><span class="h2-icon"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M12 22s8-4 8-10V5l-8-3-8 3v7c0 6 8 10 8 10z"/></svg></span>Safety & Efficacy</h2>
      <p>Safety is engineered into the sequence, not just monitored in the clinic.</p>
      
      <ul>
        <li><strong>Safety Switches</strong> ‚Äî <strong>iCasp9</strong> (Standard, >95% clearance), <strong>tEGFR</strong> (ADCC), <strong>RQR8</strong> (CD20 mimotope).</li>
        <li><strong>Logic Gating</strong> ‚Äî <strong>SynNotch</strong> (AND gate for specificity), <strong>iCAR</strong> (Inhibitory CAR for normal tissue protection).</li>
        <li><strong>Toxicity Management</strong> ‚Äî 4-1BB to reduce CRS peak; Local delivery to minimize systemic toxicity.</li>
      </ul>

      <h2 id="full-report"><span class="h2-icon"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M14 2H6a2 2 0 0 0-2 2v16a2 2 0 0 0 2 2h12a2 2 0 0 0 2-2V8z"/><polyline points="14 2 14 8 20 8"/><line x1="16" y1="13" x2="8" y2="13"/><line x1="16" y1="17" x2="8" y2="17"/><polyline points="10 9 9 9 8 9"/></svg></span>Full Design Report</h2>
      <p>We deliver a comprehensive design package ready for synthesis and testing.</p>
      
      <ul>
        <li><strong>Construct Sequences</strong> ‚Äî Optimized DNA/Amino Acid sequences for the full CAR construct (Binder-Hinge-TM-Signaling-Armor).</li>
        <li><strong>Vector Map</strong> ‚Äî Plasmid/Lentiviral vector design with promoters (EF1Œ±/MSCV) and regulatory elements.</li>
        <li><strong>Rationale</strong> ‚Äî Detailed explanation of component selection based on disease context and target topology.</li>
        <li><strong>Experimental Plan</strong> ‚Äî Recommended in vitro (killing, cytokine) and in vivo (mouse model) validation protocols.</li>
      </ul>

      <h2 id="submit"><span class="h2-icon"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><line x1="22" y1="2" x2="11" y2="13"/><polygon points="22 2 15 22 11 13 2 9 22 2"/></svg></span>Submit Inquiry</h2>
      <p>Tell us about your target and disease indication. We will provide a tailored CAR design proposal.</p>

      <div class="form-section">
        <form id="inquiry-form" action="https://formspree.io/f/mnjblezr" method="POST">
          <input type="hidden" name="_subject" value="InSynBio CAR-T Inquiry">
          <input type="hidden" name="_next" value="https://insynbio.com/thanks.html">
          
          <h3 style="margin-top: 0; margin-bottom: 20px;">Project Details</h3>
          <div class="form-row">
            <div class="form-group">
              <label>Disease Type *</label>
              <select name="disease_type" required>
                <option value="" disabled selected>Select...</option>
                <option value="solid">Solid Tumor (ÂÆû‰ΩìÁò§)</option>
                <option value="liquid">Hematologic Malignancy (Ë°ÄÊ∂≤Áò§)</option>
                <option value="autoimmune">Autoimmune Disease (Ëá™Ë∫´ÂÖçÁñ´)</option>
                <option value="other">Other (ÂÖ∂‰ªñ)</option>
              </select>
            </div>
            <div class="form-group">
              <label>Target Antigen *</label>
              <input type="text" name="target" placeholder="e.g., GPC3, BCMA, CD19" required>
            </div>
          </div>

          <div class="form-group full">
            <label>Service Requirements</label>
            <div class="check-group">
              <div class="check-item"><input type="checkbox" name="services" id="s1" value="design"><label for="s1">De Novo CAR Design</label></div>
              <div class="check-item"><input type="checkbox" name="services" id="s2" value="optimization"><label for="s2">Sequence Optimization (Humanization/Affinity)</label></div>
              <div class="check-item"><input type="checkbox" name="services" id="s3" value="cro"><label for="s3">CRO Validation (In vitro/In vivo)</label></div>
              <div class="check-item"><input type="checkbox" name="services" id="s4" value="full"><label for="s4">Full End-to-End Package</label></div>
              <div class="check-item"><input type="checkbox" name="services" id="s_other" value="other"><label for="s_other">Other / Custom Request</label></div>
            </div>
          </div>

          <div class="form-group full">
            <label>Chassis / Delivery Preference (Optional)</label>
            <div class="check-group">
              <div class="check-item"><input type="checkbox" name="chassis" id="c1" value="cart"><label for="c1">CAR-T (Œ±Œ≤)</label></div>
              <div class="check-item"><input type="checkbox" name="chassis" id="c2" value="carnk"><label for="c2">CAR-NK</label></div>
              <div class="check-item"><input type="checkbox" name="chassis" id="c3" value="carm"><label for="c3">CAR-M</label></div>
              <div class="check-item"><input type="checkbox" name="chassis" id="c4" value="gamma"><label for="c4">Œ≥Œ¥ T</label></div>
              <div class="check-item"><input type="checkbox" name="chassis" id="c5" value="invivo"><label for="c5">In Vivo CAR (e.g. LNP-mRNA)</label></div>
            </div>
          </div>

          <div class="form-group full">
            <label for="message">Additional context (e.g., binder sequence, specific constraints)</label>
            <textarea id="message" name="message" placeholder="Describe your project goals..." style="min-height: 100px;"></textarea>
          </div>
          <div class="form-group full" style="margin-top: 16px;">
            <div class="check-group">
              <div class="check-item">
                <input type="checkbox" name="newsletter" id="newsletter" value="yes">
                <label for="newsletter">
                  Join mailing list for news and service updates
                  
                </label>
              </div>
            </div>
          </div>

          <h3 style="margin-top: 24px; margin-bottom: 20px;">Contact Information</h3>
          <div class="form-row">
            <div class="form-group">
              <label for="fname">First Name *</label>
              <input type="text" id="fname" name="fname" required>
            </div>
            <div class="form-group">
              <label for="lname">Last Name *</label>
              <input type="text" id="lname" name="lname" required>
            </div>
          </div>
          <div class="form-row">
            <div class="form-group">
              <label for="org">Organization *</label>
              <input type="text" id="org" name="org" required>
            </div>
            <div class="form-group">
              <label for="email">Email *</label>
              <input type="email" id="email" name="email" required>
            </div>
          </div>
          
          <div style="margin-top: 24px;">
            <button type="submit" class="btn">Submit Inquiry</button>
          </div>
        </form>
      </div>

      <!-- Contact -->
      <h2 id="contact"><span class="h2-icon"><svg width="18" height="18" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2"><path d="M4 4h16c1.1 0 2 .9 2 2v12c0 1.1-.9 2-2 2H4c-1.1 0-2-.9-2-2V6c0-1.1.9-2 2-2z"/><polyline points="22,6 12,13 2,6"/></svg></span>Contact</h2>
      <p>For inquiries, please submit the form above or email us directly:</p>
      
      <p style="margin: 16px 0;"><a href="mailto:contact@insynbio.com" style="font-size: 18px; font-weight: 600; color: var(--primary);">contact@insynbio.com</a></p>
      <p  style="color: var(--text-muted); font-size: 14px;">We typically respond within 1‚Äì2 business days.</p>
      
      <footer class="site-footer">
        <p>¬© 2026 InSynBio ¬∑ <a href="https://insynbio.com">insynbio.com</a> ¬∑ <a href="mailto:contact@insynbio.com">contact@insynbio.com</a></p>
      </footer>
    </main>
  </div>
  <script>
    function setTopNavActive() {
      var hash = window.location.hash || '';
      document.querySelectorAll('.top-header-nav a[href^="#"]').forEach(function(a) {
        a.classList.toggle('active', a.getAttribute('href') === hash);
      });
    }
    setTopNavActive();
    window.addEventListener('hashchange', setTopNavActive);
    document.querySelectorAll('.nav-link').forEach(a => {
      a.addEventListener('click', function(e) {
        e.preventDefault();
        const id = this.getAttribute('href').slice(1);
        document.getElementById(id)?.scrollIntoView({ behavior: 'smooth' });
        document.querySelectorAll('.nav-link').forEach(l => l.classList.remove('active'));
        this.classList.add('active');
      });
    });
    const sections = ['platform','library','strategy','engineering','example','safety','full-report','submit','contact'];
    const observer = new IntersectionObserver((entries) => {
      entries.forEach(entry => {
        if (!entry.isIntersecting) return;
        const id = entry.target.id;
        document.querySelectorAll('.nav-link').forEach(a => {
          a.classList.toggle('active', a.getAttribute('href') === '#' + id);
        });
      });
    }, { rootMargin: '-20% 0px -60% 0px' });
    sections.forEach(id => { const el = document.getElementById(id); if (el) observer.observe(el); });
    
    // Form submission
    const form = document.getElementById('inquiry-form');
    if (form) {
      form.addEventListener('submit', function(e) {
        e.preventDefault();
        const btn = form.querySelector('button[type="submit"]');
        const originalText = btn.innerText;
        btn.disabled = true;
        btn.innerText = 'Submitting...';

        const formData = new FormData(form);
        fetch(form.action, {
          method: 'POST',
          body: formData,
          headers: { 'Accept': 'application/json' }
        }).then(response => {
          if (response.ok) {
            window.location.href = 'thanks.html';
          } else {
            alert("Oops! There was a problem submitting your form");
            btn.disabled = false;
            btn.innerText = originalText;
          }
        }).catch(error => {
          alert("Oops! There was a problem submitting your form");
          btn.disabled = false;
          btn.innerText = originalText;
        });
      });
    }
  </script>
</body>
</html>
